HLA Contributions to Risk and Protection for Anti-Centromere Autoantibody-Positive Scleroderma

被引：0

作者：

Remmers, Elaine F. ^{[1
]}

Alexander, Theresa ^{[2
]}

Morgan, Nadia D. ^{[3
]}

Shah, Ami A. ^{[4
]}

Mayes, Maureen D. ^{[5
]}

Adeyemo, Adebowale ^{[1
]}

Doumatey, Ayo ^{[1
]}

Bentley, Amy ^{[1
]}

Shriner, Daniel ^{[1
]}

Chandrasekharappa, Settara C. ^{[1
]}

Carns, Mary A. ^{[6
]}

Chung, Lorinda ^{[7
]}

Criswell, Lindsey A. ^{[8
]}

Derk, Chris T. ^{[9
]}

Domsic, Robyn T. ^{[10
]}

Gladue, Heather ^{[11
]}

Goldberg, Avram ^{[12
]}

Gordon, Jessica K. ^{[13
]}

Hsu, Vivien ^{[14
]}

Jan, Reem ^{[15
]}

Khanna, Dinesh ^{[16
]}

Medsger, Thomas A. ^{[17
]}

Ramos, Paula S. ^{[18
]}

Trojanowski, Marcin A. ^{[19
]}

Saketkoo, Lesley Ann ^{[20
]}

Schiopu, Elena ^{[21
]}

Shanmugam, Victoria ^{[22
]}

Korman, Benjamin D. ^{[23
,24
]}

Kron, Brynn ^{[8
]}

Louis Bridges, S., Jr. ^{[25
]}

Kolstad, Kathleen D. ^{[26
]}

Bernstein, Elana J. ^{[27
]}

Kafaja, Suzanne ^{[28
]}

Maksimowicz-McKinnon, Kathleen ^{[29
]}

Silver, Rick ^{[30
]}

Steen, Virginia D. ^{[31
]}

Varga, John ^{[32
]}

Rotimi, Charles ^{[1
]}

Boin, Francesco ^{[33
]}

Wigley, Fredrick M. ^{[34
]}

Kastner, Daniel L. ^{[35
]}

Gourh, Pravitt ^{[36
]}

机构：

[1] NHGRI, NIH, Bethesda, MD 20892 USA

[2] NIH, Bldg 10, Bethesda, MD 20892 USA

[3] Johns Hopkins Univ, Sch Med, Rhetimatol, Baltimore, MD USA

[4] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA

[5] Univ Texas Houston, McGovern Med Sch, Rheumatol, Houston, TX USA

[6] Northwestern Univ, Feinberg Sch Med, Scleroderma Program, Chicago, IL 60611 USA

[7] Stanford Univ, Sch Med, Immunol & Rheumatol, Palo Alto, CA 94304 USA

[8] Univ Calif San Francisco, San Francisco, CA 94143 USA

[9] Univ Penn, Rheumatol, Philadelphia, PA 19104 USA

[10] Univ Pittsburgh, Med Rheumatol, Pittsburgh, PA USA

[11] Arthrit & Osteoporosis Consultants Carolinas, Rheumatol, Charlotte, NC USA

[12] NYU, Langone Med Ctr, New York, NY USA

[13] Hosp Special Surg, Rheumatol, 535 E 70th St, New York, NY 10021 USA

[14] Robert Wood Johnson Univ, Scleroderma Program, Rheumatol, New Brunswick, NJ USA

[15] Univ Chicago, Rheumatol, Med, Chicago, IL 60637 USA

[16] Univ Michigan, Scleroderma Program, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA

[17] Univ Pittsburgh, Pittsburgh, PA USA

[18] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA

[19] Boston Univ, Sch Med, Boston, MA 02118 USA

[20] Tulane Univ, Sch Med, Rheumatol, 1430 Tulane Ave, New Orleans, LA 70112 USA

[21] Univ Michigan, Ann Arbor, MI 48109 USA

[22] George Washington Univ, Rheumatol, Washington, DC USA

[23] Univ Rochester, Med Sch, Sch Med & Dent, Div Allergy Immunol & Rheumatol, Rochester, NY USA

[24] Univ Rochester, Med Sch, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY USA

[25] Univ Alabama Birmingham, Clin Immunol & Rheum, Birmingham, AL USA

[26] Stanford Univ, Med Ctr, Rheumatol, Stanford, CA 94305 USA

[27] Columbia Univ, Rheumatol, New York, NY USA

[28] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[29] Henry Ford Hosp, Rheumatol, Detroit, MI 48202 USA

[30] Med Univ SC, Rheumatol, Charleston, SC USA

[31] Medstar Georgetown Univ Hosp, Rheumatol, Washington, DC USA

[32] Northwestern Univ, Chicago, IL 60611 USA

[33] Univ Calif San Francisco, Rheumatol, San Francisco, CA 94143 USA

[34] Johns Hopkins Univ, Rheum Div, Mason F Lord, Baltimore, MD USA

[35] NHGRI, Inflammatory Dis Sect, NIH, Bethesda, MD 20892 USA

[36] NIAMS, Rheumatol, NIH, Bethesda, MD USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1962

引用

页数：2

共 50 条

[1] Spontaneous Pneumomediastinum in a Patient With Anti-Centromere Antibody-Positive Limited Scleroderma
Haroon, Muhammad
McLaughlin, Patrick
Henry, Michael
Harney, Sinead
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2011, 17 (01) : 42 - 43
[2] ANTI-CENTROMERE ANTIBODY POSITIVE DIFFUSE SCLERODERMA IS UNCOMMON BUT HAS A DISTINCT CLINICAL PHENOTYPE
Caetano, J.
Nihtyanova, S.
Harvey, J.
Ong, V.
Denton, C.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 752 - 753
[3] Anti-centromere autoantibody in a patient evolving from a lupus/Sjogren's overlap to the CREST variant of scleroderma
Ford, AL
Kurien, BT
Harley, JB
Scofield, RH
JOURNAL OF RHEUMATOLOGY, 1998, 25 (07) : 1419 - 1424
[4] Phlebosclerosis of the colon with positive anti-centromere antibody
Kitamura, T
Kubo, M
Nakanishi, T
Fushimi, H
Yoshikawa, K
Taenaka, N
Furukawa, T
Tsujimura, T
Kameyama, M
INTERNAL MEDICINE, 1999, 38 (05) : 416 - 421
[5] Fine specificity mapping of scleroderma autoantigens targeted by anti-centromere autoantibodies
Matousek-Ronck, J
James, JA
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S129 - S129
[6] Analysis of development of anti-centromere autoantibody in a patient evolving from a lupus/Sjogren's overlap to the crest variant of scleroderma.
Ford, AL
Kurien, BT
Harley, JB
Scofield, RH
ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 320 - 320
[7] ASSOCIATION OF THE IRF7 REGION WITH ANTI-CENTROMERE AUTOANTIBODY PRODUCTION IN SSc
Carmona, F.
Gutala, R.
Simeon, C. P.
Carreira, P.
Ortego Centeno, N.
Rabaneda, E. Vicente
Garcia Hernandez, F. J.
Garcia De La Pena, P.
Fernandez Castro, M.
Martinez Estupinan, L.
Egurbide, M. V.
Tsao, B. P.
Gourh, P.
Agarwal, S. K.
Assassi, S.
Mayes, M. D.
Arnett, F. C.
Tan, F. K.
Martin, J.
RHEUMATOLOGY, 2012, 51 : 24 - 24
[8] Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)
Admou, B.
Arji, N.
Seghrouchni, F.
Missoum, H.
El Fenniri, L.
Amghar, S.
El Aouad, R.
ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (03) : 291 - 297
[9] THE ANTI-CENTROMERE ANTIBODY - A BIOLOGICAL MARKER OF THE CREST SYNDROME AS DISTINCT FROM SCLERODERMA
ROUQUETTEGALLY, AM
STERN, MH
PROST, AC
ABUAF, N
HOMBERG, JC
COMBRISSON, A
PRESSE MEDICALE, 1985, 14 (28): : 1497 - 1500
[10] DISEASE PROGRESSION IN ANTI-CENTROMERE POSITIVE SYSTEMIC SCLEROSIS PATIENTS
Hoekstra, E.
Ahmed, S.
Ueckert, D.
Ajmone-Marsan, N.
Kies, P.
Ninaber, M.
Heuvers, M.
Geelhoed, J.
Huizinga, T.
Vries-Bouwstra, J. K. De
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83

← 1 2 3 4 5 →